Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 151 AL 165

Ultrasound-induced blood-brain barrier opening in Alzheimer's disease: a systematic review of clinical studies

Niknam N, Songhori N, Nekahi N, Kavian M, Khosravi F, Fard AM, Moshiri Y, Haghshenas N, Sadegh MH, Torabi P.

Aging Clin Exp Res. 2026 Jun 2;38(1):171. doi: 10.1007/s40520-026-03408-1.

The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021-2025 State-of-the-Art Review of Clinical and Preclinical Evidence

Chiatto LM, Buccarello L, Carota G, Calabrò RS, Rifici C, Esposito E, Ardizzone A, Caruso G.

Pharmacol Res Perspect. 2026 Jun;14(3):e70280. doi: 10.1002/prp2.70280.

Targeting inflammaging in Alzheimer's disease: molecular pathways and emerging pharmacotherapies

Alotaibi MO, Al-Kuraishy HM, Fahad EH, Abdelaziz AM, El-Saber Batiha G.

Inflammopharmacology. 2026 Jul;34(7):4445-4461. doi: 10.1007/s10787-026-02281-8. Epub 2026 Jun 8.

Repurposing antidiabetics for Alzheimer's disease and related neurodegenerative disorders: Translational challenges and role of nanoparticle-mediated CNS targeting

Alnsour L, Al-Samydai A, Sadek B, Akour A.

Biomed Pharmacother. 2026 Jul;200:119614. doi: 10.1016/j.biopha.2026.119614. Epub 2026 Jun 8.

A comprehensive exploration of the structure-activity relationships, multitarget strategies, and therapeutic mechanisms of triazole scaffolds in Alzheimer's disease

Malvankar A, Raut M, Singh SK, Singh R, Mahindroo N, Bajad N.

Future Med Chem. 2026 Jul;18(14):1925-1941. doi: 10.1080/17568919.2026.2684615. Epub 2026 Jun 9.

Semaglutide showed limited improvements in patients with Alzheimer's disease: Revisiting the evoke and evoke + clinical trials

Hölscher C.

J Alzheimers Dis. 2026 Aug;112(3):1377-1381. doi: 10.1177/13872877261458402. Epub 2026 Jun 9.

Targeting Brain Cholesterol Homeostasis in Alzheimer's Disease: Mechanisms and Therapeutic Perspectives

Ruthirakuhan M, Taha AY, Swardfager W.

J Neurochem. 2026 Jun;170(6):e70492. doi: 10.1111/jnc.70492.

Current status and challenges in targeting circulating amyloid-β carriers for Alzheimer's disease therapy

Ren L, Luo XQ, Mi FY, Yu CY.

Neuroscience. 2026 Aug 28;610:189-197. doi: 10.1016/j.neuroscience.2026.06.009. Epub 2026 Jun 13.

Advances in nano-TCM for Alzheimer's disease: lipid-based carriers integrated with innovative delivery strategies

Deng L, Li H, Yang S, Chen F, Qiao J, Bao H, Wang X, Fang S, Xu B, Tang Z.

J Nanobiotechnology. 2026 Jun 15;24(1):794. doi: 10.1186/s12951-026-04654-1.

PCSK9 in bridging metabolism and neurodegeneration: a new paradigm for alzheimer's treatment

Sood S, Singh S, Singh TG.

Metab Brain Dis. 2026 Jun 17;41(1):137. doi: 10.1007/s11011-026-01900-1.

Novel aptamers targeting heparan sulfate for delivery of RNA therapeutics in Alzheimer's disease

Mehmood A, Shah AZ, Martinez Juarez JA, Liu X, Jiang H, Wang X.

Prog Biomed Eng (Bristol). 2026 Jul 2;8(3). doi: 10.1088/2516-1091/ae7eb9.

Plasmalogens in Alzheimer's Disease: A Narrative Review of Dietary Sources, Metabolism, and Neuroprotective Mechanisms

Zhang Y, Chen J, Jiang J, Yang N, Guo S, Gao F, Zhang C, Weng Q, Xiao H, Luo J, Chen J, Shen Q, Shen G, Ji L.

J Agric Food Chem. 2026 Jul 1;74(25):19375-19392. doi: 10.1021/acs.jafc.6c05250. Epub 2026 Jun 17.

Amino Acid-Driven Gold Nanochaperone Platforms for Alzheimer's Therapy: A Mechanistic and Design Framework for Protein Misfolding Modulation

Siddiqui F, Khanam S, Faruqui T, Mishra P, Mahmood S, Mir SS, Khan S.

Mol Neurobiol. 2026 Jun 23;63(1):713. doi: 10.1007/s12035-026-05955-0.

Redirecting Alzheimer's disease therapeutics: Multitarget drugs and complementary non-pharmacological strategies

Martínez-Orozco H, Andrade-Guerrero J, Pastén-Castrejón NJ, Rodríguez-Tanty C, Diaz-Miranda SY.

Alzheimers Dement. 2026 Jun;22(6):e71589. doi: 10.1002/alz.71589.

Targeting of RhoA-ROCK pathway activators and linked molecular signaling in Alzheimer's disease: The paving dawn for future therapy

Al-Kuraishy HM, Fahad EH, Jabir MS, Rafeeq MF, Sulaiman GM, Amara IB, Albuhadily AK, Al-Gareeb AI.

Neuroscience. 2026 Sep 11;611:10-18. doi: 10.1016/j.neuroscience.2026.06.032. Epub 2026 Jun 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias